CLINICAL_TRIALS
trial_result
· 2008-12-01
Clinical Trial Update: Soluble CD23 Expression in Asthma Patients Treated With OMA [NA]
Summary
A University of Mississippi Medical Center–sponsored clinical trial evaluating soluble CD23 expression in asthma patients treated with omalizumab was terminated…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: University of Mississippi Medical Center | Conditions: Asthma | NA | Status: TERMINATED